Mary M. Rozenman, See Remarks at Aimmune Therapeutics, Inc. (AIMT), sold 3,614 shares at $33.10 ($120K) on 2018-03-01, disclosed to the SEC on 2018-03-05.
Open-market sale of $120k AIMT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.10 | 1,807 | $60K | 50.0% |
| 2 | $33.10 | 1,807 | $60K | 50.0% |
| Total | $33.10 avg | 3,614 | $120K | 100% |
| Filing → |
| AIMT | SELL | 2017-12-28 | $381K | — | Filing → |
| AIMT | SELL | 2017-09-11 | $675K | — | Filing → |
| AIMT | SELL | 2017-07-17 | $320K | — | Filing → |